| Edoxaban versus warfarin in patients with atrial fibrillation AEM Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL ... N Engl J Med. 369 (22), 2093-2104, 2013 | 5844* | 2013 |
| Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease PTR Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA ... N Engl J Med . 376 (18), 1713-1722, 2017 | 5689* | 2017 |
| Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia N Engl J Med. 380 (1), 11-22., 2019 | 2889* | 2019 |
| Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial F Investigators Lancet 390 (10106), 1962-1971, 2017 | 659 | 2017 |
| Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT BCM Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Doyle ... J Am Coll Cardiol 73 (22), 2791-2802, 2019 | 288 | 2019 |
| Rationale and design of REDUCE-IT: Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial BCM Bhatt DL, Steg PG, Brinton EA, Jacobson TA, Miller M, Tardif JC, Ketchum ... Clin Cardiol. 40 (3), 138-148, 2017 | 272 | 2017 |
| Анализ вегетативной регуляции сердечного ритма на различных этапах индивидуального развития человека ОВ Коркушко, ВБ Шатило, ТВ Шатило, ЕВ Короткая Физиология человека 17 (2), 31-39, 1991 | 230 | 1991 |
| Autonomic control of cardiac chronotropic function in man as a function of age: assessment by power spectral analysis of heart rate variability OV Korkushko, VB Shatilo, YI Plachinda, TV ShatiloShatilo Journal of the autonomic nervous system 32 (3), 191-198, 1991 | 177 | 1991 |
| Анализ вариабельности ритма сердца в клинической практике (возрастные аспекты) ОВ Коркушко, АВ Писарук, ВБ Шатило, ВЮ Лишневская, ... Киев: ИПЦ" Алкон, 2002 | 161 | 2002 |
| Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative a NSE Ridker PM, Bhatt DL, Pradhan AD, Glynn RJ, MacFadyen JG, ... Lancet 401 (10384), 1293-1301, 2023 | 152 | 2023 |
| Пептидные препараты тимуса и эпифиза в профилактике ускоренного старения ОВ Коркушко, ВХ Хавинсон, ГМ Бутенко, ВБ Шатило СПб.: Наука, 2002 | 150 | 2002 |
| Effects of intermittent hypoxia training on exercise performance, hemodynamics, and ventilation in healthy senior men VB Shatilo, OV Korkushko, VA Ischuk, HF Downey, TV Serebrovskaya High altitude medicine & biology 9 (1), 43-52, 2008 | 116 | 2008 |
| Пинеальная железа: пути коррекции при старении ОВ Коркушко, ВХ Хавинсон, ВБ Шатило Наука, 2006 | 108 | 2006 |
| Intermittent Hypoxia-Hyperoxia Training Improves Cognitive Function and Decreases Circulating Biomarkers of Alzheimer's Disease in Patients with Mild Cognitive Impairment: A … ZO Serebrovska, TV Serebrovska, VA Kholin, LV Tumanovska, AM Shysh, ... International Journal of Molecular Sciences 20 (21), 2019 | 82 | 2019 |
| Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial MP Schlaich, M Bellet, MA Weber, P Danaietash, GL Bakris, JM Flack, ... The Lancet 400 (10367), 1927-1937, 2022 | 72 | 2022 |
| Intermittent hypoxia training in prediabetes patients: Beneficial effects on glucose homeostasis, hypoxia tolerance and gene expression TV Serebrovska, AG Portnychenko, TI Drevytska, VI Portnichenko, L Xi, ... Experimental Biology and Medicine 242 (15), 1542-1552, 2017 | 69 | 2017 |
| Reduction in Revascularization With Icosapent Ethyl: Insights From REDUCE-IT Revascularization Analyses BCM Peterson BE, Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA ... Circulation 143 (1), 33-44, 2021 | 62 | 2021 |
| Single-pill combination of telmisartan/amlodipine in patients with severe hypertension: results from the TEAMSTA severe HTN study VR Neutel JM, Mancia G, Black HR, Dahlöf B, Defeo H, Ley L, ... J Clin Hypertens (Greenwich) 14 (4), 206-215, 2012 | 57* | 2012 |
| Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial Infarction. RITI Gaba, P., Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A ... Journal of the American College of Cardiology 79 (17), 1660–1671, 2022 | 51 | 2022 |
| Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG BCM Verma S, Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Dhingra ... Circulation. 144 (23), 1845-1855, 2021 | 45 | 2021 |
